The Motley Fool · Jun 16, 2023
Is Tilray Stock a Buy Now?
It would be quite a contrarian move to load up on the company's shares these days.
HE
NASDAQ · HEXO
HEXO Corp.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.71
Up+$0.02 (+2.45%)
Updated Sep 18, 2026, 4:13 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 31.24M
- P/E ratio
- -0.02
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 298.45K
- Avg. volume
- 354.78K
Price performance
HEXO price history
1M range · 0 trading sessions · Daily adjusted prices
HEXO does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest HEXO news
The latest Smart Investors Daily articles mentioning HEXO.
Stock researchCompany · Overview
HEXO research
Overview
Company profile and research snapshot.
Company profile
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $1.23
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 16, 2023 | Canaccord Genuity | Hold | — |
| Jun 15, 2022 | Alliance Global Partners | Neutral | — |
| Mar 4, 2022 | Cantor Fitzgerald | Neutral | — |
| Mar 4, 2022 | Canaccord Genuity | Speculative Buy | — |
| Jan 27, 2022 | Jefferies | Hold | — |
News briefing
No generated briefing is available yet.
Zacks Investment Research · Jun 14, 2023
HEXO (HEXO) Reports Q3 Loss, Lags Revenue Estimates
HEXO (HEXO) delivered earnings and revenue surprises of -900% and 15.51%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Jun 1, 2023
The Cooper Companies (COO) Q2 Earnings and Revenues Surpass Estimates
The Cooper Companies (COO) delivered earnings and revenue surprises of 2.33% and 1.75%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
MarketWatch · May 26, 2023
Tilray stock drops nearly 20% after convertible notes offered to help pay down debt
Tilray's share price dropped after hours Thursday after the cannabis company filed a convertible note offering to buy back older ones before Hexo deal closes.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
